Webinar Summary
About the webinar:
GI side effects are the number one reason patients abandon GLP-1 therapy. Nausea, early satiety, constipation, diarrhea, dyspepsia are all examples of predictable consequences of how GLP-1 receptor agonists reshape motility, bile flow, gastric emptying, and gut–brain signaling.
This session connects the mechanism to the management. We’ll unpack why these symptoms occur, then translate that physiology into an integrative toolkit: dietary guidance, lifestyle shifts, and evidence-based nutraceuticals, mapped to the specific symptom clusters you see in practice. You’ll leave with a clinical roadmap you can apply immediately to improve tolerability, protect outcomes, and keep patients on therapy safely.
You will learn how to:
- Explain how GLP-1 medications alter gut motility, gastric emptying, bile flow, and gut–brain signaling.
- Apply functional medicine frameworks to assess digestive health in GLP-1 users.
- Match integrative strategies—nutrition, lifestyle, and targeted nutraceuticals—to major GI symptom clusters.
- Build an actionable plan that supports long-term metabolic and GI health throughout GLP-1 therapy.
About Metagenics:
Metagenics is a science driven wellness brand rooted in over 40 years of clinical research and practitioner partnership. Trusted by healthcare professionals, Metagenics delivers precision crafted, professional grade supplements designed to work with the body and deliver results you can feel. Through clinically validated ingredients, transparent quality standards, and innovation across key health systems, Metagenics redefines supplements from guesswork to measurable outcomes. https://www.metagenics.com/en-us
View Now
